REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 401 filers reported holding REPLIGEN CORP in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $57,561 | +10.0% | 362 | -2.2% | 0.00% | 0.0% |
Q2 2023 | $52,340 | +3.3% | 370 | +22.9% | 0.00% | 0.0% |
Q1 2023 | $50,676 | -87.6% | 301 | -87.5% | 0.00% | -87.9% |
Q4 2022 | $408,037 | -10.7% | 2,410 | -1.4% | 0.03% | -23.3% |
Q3 2022 | $457,000 | +10.4% | 2,445 | -4.0% | 0.04% | +22.9% |
Q2 2022 | $414,000 | -13.9% | 2,548 | -0.4% | 0.04% | 0.0% |
Q1 2022 | $481,000 | -36.5% | 2,558 | -10.6% | 0.04% | -18.6% |
Q4 2021 | $757,000 | -7.3% | 2,860 | +1.1% | 0.04% | -14.0% |
Q3 2021 | $817,000 | +742.3% | 2,828 | +483.1% | 0.05% | +733.3% |
Q2 2021 | $97,000 | +3.2% | 485 | +0.8% | 0.01% | -14.3% |
Q1 2021 | $94,000 | -12.1% | 481 | -14.0% | 0.01% | -12.5% |
Q4 2020 | $107,000 | – | 559 | – | 0.01% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 19 | -29.6% | 0.00% | – |
Q4 2019 | $2,000 | – | 27 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2019 | $4,000 | +100.0% | 45 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | – | 45 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Q3 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |